RE: Evening all12 Mar 2026 17:09
Subject to approval at a general meeting due to be held on 26th March 2026, the company is proposing a capital reorganisation whereby holders will receive 1 new ordinary share in place of every 10 existing ordinary shares held.
The company is also proposing to change its name to Coiled Therapeutics Plc.
The company has also announced its intention to cancel its listing on the official list and to apply for admission to trading on AIM with such admission expected to take place on 27th March2026.
If approved, your account will be updated accordingly in due course.